RBC Capital Reiterates Outperform on Repligen, Maintains $205 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital has reiterated its 'Outperform' rating for Repligen (NASDAQ:RGEN) and maintained a price target of $205.
September 26, 2024 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its 'Outperform' rating for Repligen and maintained a price target of $205, indicating confidence in the company's future performance.
The reiteration of an 'Outperform' rating and maintenance of a $205 price target by RBC Capital suggests a positive outlook for Repligen. This can boost investor confidence and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100